Advanced Metastatic Non Small Cell Lung Cancer Nsclc clinical trials

Explore recruiting advanced metastatic non small cell lung cancer nsclc clinical trials.

Recruiting advanced metastatic non small cell lung cancer nsclc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Metastatic Non Small Cell Lung Cancer Nsclc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TACTI-004, a double-blinded, randomized phase 3 trial in patients with advanced/metastatic non-small cell lung cancer (NSCLC) receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (PD-1 antagonist) and chemotherapy.

Romania, Lithuania, Bulgaria, Latvia, Greece, Spain +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Open-label, Randomized Phase 3 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) vs Investigator Choice of Single-agent Chemotherapy as Third-line Treatment in Subjects with Advanced / Metastatic Non-Small Cell Lung Cancer (NSCLC)

Poland, Hungary, Romania, Spain, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

EXL-01 in combination with nivolumab for advanced NSCLC refractory to immunotherapy'

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Metastatic Non Small Cell Lung Cancer Nsclc trials by city

Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Toronto Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Vancouver Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Montreal Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Calgary Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Edmonton Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Ottawa Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Winnipeg Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Quebec City Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Hamilton Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Kitchener Advanced Metastatic Non Small Cell Lung Cancer Nsclc in London Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Halifax Advanced Metastatic Non Small Cell Lung Cancer Nsclc in New York Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Los Angeles Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Chicago Advanced Metastatic Non Small Cell Lung Cancer Nsclc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease